Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
The Greenbrier Companies
GBX
$1.54B
| $2.86M | ﹤0.01% |
103,359
+31,025
| +43% | +$796K |
|
|
KYO
3152
DELISTED
Kyocera Adr
KYO
| $2.85M | ﹤0.01% |
64,521
-6,161
| -9% | -$267K |
|
|
ZNGA
3153
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $2.85M | ﹤0.01% |
1,248,520
-89,148
| -7% | -$199K |
|
|
DNKN
3154
CALL
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $2.84M | ﹤0.01% |
60,300
+37,000
| +159% | +$1.59M |
|
3155
PUT
United States Natural Gas Fund
UNG
$473M
| $2.83M | ﹤0.01% |
26,606
-20,925
| -44% | -$2.41M |
|
3156
Mercado Libre
MELI
$96.3B
| $2.83M | ﹤0.01% |
24,027
+3,220
| +15% | +$333K |
|
3157
B&G Foods
BGS
$290M
| $2.83M | ﹤0.01% |
81,199
+46,715
| +135% | +$1.65M |
|
3158
CALL
Transocean
RIG
$5.7B
| $2.83M | ﹤0.01% |
309,300
-170,900
| -36% | -$1.7M |
|
3159
CALL
Herc Holdings
HRI
$5.48B
| $2.83M | ﹤0.01% |
89,467
-56,333
| -39% | -$1.65M |
|
|
DRII
3160
PUT
DELISTED
DIAMOND RESORTS INTL, INC
DRII
| $2.83M | ﹤0.01% |
116,300
+106,100
| +1,040% | +$2.27M |
|
3161
First Trust Multi Cap Growth AlphaDEX Fund
FAD
$579M
| $2.81M | ﹤0.01% |
56,773
| – | – |
|
3162
CALL
ICU Medical
ICUI
$4.32B
| $2.81M | ﹤0.01% |
+27,000
| New | +$2.58M |
|
|
3163
PUT
ICU Medical
ICUI
$4.32B
| $2.81M | ﹤0.01% |
+27,000
| New | +$2.58M |
|
|
EGRX
3164
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $2.8M | ﹤0.01% |
69,212
+61,390
| +785% | +$3.9M |
|
|
APOL
3165
DELISTED
Apollo Education Group Inc Class A
APOL
| $2.8M | ﹤0.01% |
340,521
-685,400
| -67% | -$5.45M |
|
|
SAAS
3166
DELISTED
inContact, Inc.
SAAS
| $2.78M | ﹤0.01% |
312,328
+283,826
| +996% | +$2.5M |
|
3167
Park National Corp
PRK
$3.75B
| $2.78M | ﹤0.01% |
30,843
-24,762
| -45% | -$2.13M |
|
3168
PUT
Ross Stores
ROST
$81.1B
| $2.77M | ﹤0.01% |
47,800
-16,800
| -26% | -$933K |
|
3169
Medifast
MED
$108M
| $2.77M | ﹤0.01% |
91,628
+7,638
| +9% | +$223K |
|
3170
Stride
LRN
$3.41B
| $2.74M | ﹤0.01% |
277,470
+12,144
| +5% | +$115K |
|
3171
PUT
TotalEnergies
TTE
$194B
| $2.74M | ﹤0.01% |
60,300
+900
| +2% | +$39.6K |
|
3172
PUT
Clorox
CLX
$11.9B
| $2.74M | ﹤0.01% |
21,700
+6,200
| +40% | +$788K |
|
3173
PUT
Lumen
LUMN
$6.65B
| $2.74M | ﹤0.01% |
85,600
-165,900
| -66% | -$4.65M |
|
3174
Erie Indemnity
ERIE
$12.4B
| $2.73M | ﹤0.01% |
29,398
+11,993
| +69% | +$1.13M |
|
3175
Ormat Technologies
ORA
$6.02B
| $2.73M | ﹤0.01% |
66,163
+24,085
| +57% | +$894K |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.